Literature DB >> 19434841

Homology modeling and docking analysis of the interaction between polyphenols and mammalian 20S proteasomes.

Matteo Mozzicafreddo1, Massimiliano Cuccioloni, Valentina Cecarini, Anna Maria Eleuteri, Mauro Angeletti.   

Abstract

Molecular docking of small ligands to biologically active macromolecules has become a valuable strategy to predict the stability of complexes between potential partners and their binding modes. In this perspective, we applied this computational procedure to rationalize the reported role of polyphenols as inhibitors of the mammalian 20S proteasomes. In particular, polyphenols were shown to modulate each proteasomal activity at different extents both in the constitutive and the inducible enzyme. We performed a flexible molecular docking analysis between a set of polyphenols previously demonstrated to have the highest binding affinity and both the constitutive (from deposited PDB structures) and homology modeled active subunits of the IFN-gamma inducible proteasome, to provide insight into the possible mechanism of interaction. Among the tested polyphenols, (-)-epigallocatechin-3-gallate showed the highest affinity for the proteasome subunits, both in terms of intermolecular energy and predicted equilibrium constants, in particular for beta5 and beta5i subunits (E(total) = -66 kcal/mol, Ki = 81.3 microM and E(Total) = -83.9 kcal/mol, Ki = 0.29 microM, respectively), known to be related to the chymotrypsin-like and BrAAP activities. Collectively, polyphenols showed a higher affinity for the inducible subunits, in agreement with previous in vitro studies. Additionally, different contributions to the interaction energy (van der Waals, electrostatic, H-bond) of proteasome-polyphenols complexes were dissected.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434841     DOI: 10.1021/ci800235m

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  11 in total

Review 1.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

2.  Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Michele Spina; Chi Nhan Tran; Maurizio Falconi; Anna Maria Eleuteri; Mauro Angeletti
Journal:  J Lipid Res       Date:  2011-02-25       Impact factor: 5.922

Review 3.  Targeting the ubiquitin-proteasome system for cancer therapy.

Authors:  Min Shen; Sara Schmitt; Daniela Buac; Q Ping Dou
Journal:  Expert Opin Ther Targets       Date:  2013-07-04       Impact factor: 6.902

Review 4.  Green tea polyphenols as proteasome inhibitors: implication in chemoprevention.

Authors:  H Yang; K Landis-Piwowar; T H Chan; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

5.  Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.

Authors:  Abhinav Grover; Ashutosh Shandilya; Virendra S Bisaria; Durai Sundar
Journal:  BMC Genomics       Date:  2010-12-02       Impact factor: 3.969

6.  Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.

Authors:  Consuelo Amantini; Maria Beatrice Morelli; Matteo Santoni; Alessandra Soriani; Claudio Cardinali; Valerio Farfariello; Anna Maria Eleuteri; Laura Bonfili; Matteo Mozzicafreddo; Massimo Nabissi; Stefano Cascinu; Giorgio Santoni
Journal:  Oncoscience       Date:  2015-03-23

7.  Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.

Authors:  Yujiao He; Junmei Huang; Ping Wang; Xiaofei Shen; Sheng Li; Lijuan Yang; Wanli Liu; Apichart Suksamrarn; Guolin Zhang; Fei Wang
Journal:  Oncotarget       Date:  2016-01-26

Review 8.  Broad targeting of resistance to apoptosis in cancer.

Authors:  Ramzi M Mohammad; Irfana Muqbil; Leroy Lowe; Clement Yedjou; Hsue-Yin Hsu; Liang-Tzung Lin; Markus David Siegelin; Carmela Fimognari; Nagi B Kumar; Q Ping Dou; Huanjie Yang; Abbas K Samadi; Gian Luigi Russo; Carmela Spagnuolo; Swapan K Ray; Mrinmay Chakrabarti; James D Morre; Helen M Coley; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; William G Helferich; Xujuan Yang; Chandra S Boosani; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; W Nicol Keith; Alan Bilsland; Dorota Halicka; Somaira Nowsheen; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2015-04-28       Impact factor: 15.707

9.  Interfering with the high-affinity interaction between wheat amylase trypsin inhibitor CM3 and toll-like receptor 4: in silico and biosensor-based studies.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Laura Bonfili; Valentina Cecarini; Mara Giangrossi; Maurizio Falconi; Shin-Ichiroh Saitoh; Anna Maria Eleuteri; Mauro Angeletti
Journal:  Sci Rep       Date:  2017-10-13       Impact factor: 4.379

10.  Engineering Pseudomonas protegens Pf-5 for nitrogen fixation and its application to improve plant growth under nitrogen-deficient conditions.

Authors:  Lorena Setten; Gabriela Soto; Matteo Mozzicafreddo; Ana Romina Fox; Christian Lisi; Massimiliano Cuccioloni; Mauro Angeletti; Elba Pagano; Antonio Díaz-Paleo; Nicolás Daniel Ayub
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.